TSXV:BTI.H - Post by User
Comment by
Boomskidon Jan 02, 2023 11:31am
101 Views
Post# 35199570
RE:What if Denali comes in and scoops up Midatech
RE:What if Denali comes in and scoops up Midatech No way!
Denali has made their play and they have to play it out. If they bought Bioasis then Denali's share price would drop 90% because the market would rightfully deduce that Denali's technology is inferior to xB3 and that Denali may face a gap of years between the drying up of new TV drugs before anything could come out of the xB3 acquisition.
And Q-Sphera may not be the big value centre you might think. The steady delivery of drugs, especially to receptors that already have their natural work to do, could impair that natural work through continuous saturation levels of the receptors. On the other hand, the periodic (bi-weekly, say) delivery to, near saturation of, and subsequent desaturation of certain receptors may allow the receptors to take a break through the half-life period of the therapeutic, and then be reengaged through redosing as drug concentration drops.
But, yes, Q-Sphera may have value, no denying it, but I doubt it's a solution for as many neurodiseases as xB3 is.
But that's not the point. Bioasis has surrendered either because of incompetence or malicious planning. That is the issue. The scientists can work out the science.
Meanwhile, "success conscious" Wall St raiders who know nothing about anything will make the big bucks on it, their own assessment of their great wisdom being refinanced with their own money.
jd